Affiliations 

  • 1 From the Sheikh Jaber Al Ahmad Al Sabah for Nuclear Medicine and Molecular Imaging Center, Kuwait City, Kuwait
  • 2 Department of Nuclear Medicine, St Gregorios International Cancer Care Centre, Pathanamthitta, Kerala, India
Clin Nucl Med, 2021 Jan;46(1):e65-e67.
PMID: 33181733 DOI: 10.1097/RLU.0000000000003354

Abstract

A 46-year-old man with end-stage renal disease and renal cell carcinoma underwent F-FDG PET/CT for initial staging followed by F-PSMA-1007 PET/CT. Unlike F-FDG, which undergoes renal clearance, F-PSMA-1007 undergoes hepatobiliary clearance and thus generates superior quality images. F-PSMA-1007 PET/CT showed intense tracer-avid left renal mass lesion (FDG nonavid); lytic bone lesions (FDG avid) and single liver lesion (FDG nonavid). This case highlights the superiority of F-PSMA-1007 over F-FDG PET/CT in identifying primary lesion as well as metastatic sites in case of renal cell carcinoma even in the presence of end-stage renal disease.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.